tradingkey.logo
tradingkey.logo
Search

BCPE Perseus Investor Ord Shs (Proposed)

KLRA
Add to Watchlist
18.760USD
+0.210+1.13%
Market hours ETQuotes delayed by 15 min
2.32BMarket Cap
--P/E TTM

BCPE Perseus Investor Ord Shs (Proposed)

18.760
+0.210+1.13%

More Details of BCPE Perseus Investor Ord Shs (Proposed) Company

Kailera Therapeutics Inc is a United States-based company. The Company is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions. Its pipeline consists of clinical- and preclinical-stage programs with injectable peptides, oral peptides, and an oral small molecule.

BCPE Perseus Investor Ord Shs (Proposed) Info

Ticker SymbolKLRA
Company nameKailera Therapeutics Inc
IPO dateApr 17, 2026
CEORenaud (Ron)
Number of employees- -
Security typeOrdinary Share
Fiscal year-end- -
Address180 Third Ave
CityWALTHAM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code02451
Phone15084409475
Websitehttps://www.kailera.com
Ticker SymbolKLRA
IPO dateApr 17, 2026
CEORenaud (Ron)

Company Executives of BCPE Perseus Investor Ord Shs (Proposed)

Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Mr. Ron Renaud
Mr. Ron Renaud
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul Burgess
Mr. Paul Burgess
Chief Operating Officer, Chief Business Officer
Chief Operating Officer, Chief Business Officer
--
--
Ms. Paula Cloghessy
Ms. Paula Cloghessy
Chief People Officer
Chief People Officer
--
--
Mr. Scott M. Akamine, J.D.
Mr. Scott M. Akamine, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Ms. Jamie Coleman
Ms. Jamie Coleman
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Douglas W. Pagan
Mr. Douglas W. Pagan
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Scott Wasserman, M.D.
Dr. Scott Wasserman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Franklin K. (Frank) Clyburn, Jr.
Mr. Franklin K. (Frank) Clyburn, Jr.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Mr. Ron Renaud
Mr. Ron Renaud
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul Burgess
Mr. Paul Burgess
Chief Operating Officer, Chief Business Officer
Chief Operating Officer, Chief Business Officer
--
--
Ms. Paula Cloghessy
Ms. Paula Cloghessy
Chief People Officer
Chief People Officer
--
--
Mr. Scott M. Akamine, J.D.
Mr. Scott M. Akamine, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Ms. Jamie Coleman
Ms. Jamie Coleman
Chief Commercial Officer
Chief Commercial Officer
--
--

FAQs

Who are the top five shareholders of BCPE Perseus Investor Ord Shs (Proposed)?

The top five shareholders of BCPE Perseus Investor Ord Shs (Proposed) are: ,
tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.